Companies
Company Logo
Oneliner
Company Logo
Oneliner
Add Entity
snc-logo

Startup Nation Finder

Ecosystem
Startups
Investors
Hubs
Multinationals
Reports toggle reports submenu
My Watchlists
My Saved Searches
Following
Inbox
About Us
Glossary

snackbar-icon
title

Create new Watchlist

Watchlist name*
Watchlist must have a valid name.
Description (optional)
Notifications Off
Public content (accessible by all Finder users)

Add to watchlist

    Hey #USER_FULLNAME#!
    Claim #COMPANY_NAME#’s profile to become an administrator with editing privileges in
    #COMPANY_NAME#’s page on Startup Nation Finder

    The invitation to claim the profile was originally sent to

    or  

    Hey #USER_FULLNAME#!
    Claim #COMPANY_NAME#’s profile to become an administrator with editing privileges in
    #COMPANY_NAME#’s page on Startup Nation Finder

    Suggest Edits

    Let us know what you think is inaccurate or missing.
    We will check it out and update the profile if needed.

    Claim Profile

    Please provide us the following information. Note that you need to have an email in this organization in order to claim the profile.

    Already have an account? Login

    Verify your email

    We’ve sent a verification link to [email protected]
    Reset password
    Don't have an account? Sign up

    Check your mailbox

    We sent you an email with further instructions to
    [email protected]

    Do not forget to check your spam folder

    Didn’t get the email? Resend email or Contact us

    Password must contain at least 8 characters, one digit, one uppercase and one lowercase letter.

    Save Search

    Search must have a valid name.

    Rename Search

    Search must have a valid name.
    Delete Saved Search Confirmation
    search will be permanently removed from Finder.
    News Analysis
    Search Startups

    Non Active, Tagged as ('cancer-therapy') Startups

    Filters
    Clear

    Search by tag (1)

    All of
    Any of
    None of

    Sector 

    Primary Sector 

    Target Customer 

    Core Technology 

    Funding Stage 

    Founded 

    Total Raised 

    Min
    Max

    Market Cap 

    Min
    Max

    Business Models 

    Product Stage 

    Employees 

    Location 

    Status (1)

    8 Startups 0 In the News 0 Recently Updated
    • Total Funding
      $82.35M
      Raised
      11
      Events
    • Private Funding
      $61.05M
      Raised
      4
      Rounds
    • Public Offerings
      $21.3M
      Raised
      5
      Offerings
    • M&A
      $0
      Raised
      2
      Deals
    Funding
    Number of Employees
    Rounds / Deals
    Funding Stage
    Tags

    There aren’t any companies that match your search
    you can try looking for something else.

    Zion Medical logo

    Zion Medical

    Presumed Inactive
    ?
    Based on data collected from different sources by our team,
    there are indicators that suggest that this company is no longer active. However, this information may not be accurate. If you believe this information should be updated, please .
    For more details, you can read our .
    Destruction of Cells Infected with HIV or Cancer
    2014 B2B 1-10 Pre-Funding Undisclosed
    cancer-therapy
    oncology
    drug-discovery
    pharmaceuticals
    cancer
    pharma-companies
    Cellect Biotechnology logo

    Cellect Biotechnology

    Presumed Inactive
    ?
    Based on data collected from different sources by our team,
    there are indicators that suggest that this company is no longer active. However, this information may not be accurate. If you believe this information should be updated, please .
    For more details, you can read our .
    Immune System Regeneration
    2011 B2B 11-50 Public $24.26M
    therapeutics
    immunology
    regenerative-medicine
    cell-therapy
    bioprocess
    biotechnology
    medical-technologies
    stem-cells
    chronic-patients
    cancer
    medical-devices
    academia
    cancer-therapy
    diabetes
    pharma-companies
    laboratories
    healthcare-providers
    BioSight logo

    BioSight

    Presumed Inactive
    ?
    Based on data collected from different sources by our team,
    there are indicators that suggest that this company is no longer active. However, this information may not be accurate. If you believe this information should be updated, please .
    For more details, you can read our .
    Therapeutics for Oncology and Hematological Disorders
    1999 B2B 1-10 Acquired $62.5M
    chemotherapy
    cancer
    drug-discovery
    biopharmaceutical
    targeted-therapy
    pharmaceuticals
    cancer-therapy
    oncology
    hematology
    CureTech logo

    CureTech

    Presumed Inactive
    ?
    Based on data collected from different sources by our team,
    there are indicators that suggest that this company is no longer active. However, this information may not be accurate. If you believe this information should be updated, please .
    For more details, you can read our .
    Cancer Immunotherapy
    2001 B2B 51-200 Seed $4M
    biopharmaceutical
    biotechnology
    immunology
    cancer
    antibodies
    cancer-therapy
    vaccines
    TanoMed logo

    TanoMed

    Presumed Inactive
    ?
    Based on data collected from different sources by our team,
    there are indicators that suggest that this company is no longer active. However, this information may not be accurate. If you believe this information should be updated, please .
    For more details, you can read our .
    Immunotherapy Solutions for GI Cancers
    2020 B2B2C 1-10 Pre-Funding Undisclosed
    cancer
    immunotherapy
    pharma-companies
    oncology
    nanotechnology
    gastroenterology
    biotechnology
    cancer-therapy
    personalized-medicine
    Novitero logo

    Novitero

    Presumed Inactive
    ?
    Based on data collected from different sources by our team,
    there are indicators that suggest that this company is no longer active. However, this information may not be accurate. If you believe this information should be updated, please .
    For more details, you can read our .
    Cancer Drugs to Bypass Resistance Mutations
    2014 B2B 1-10 Pre-Funding $0
    drug-design
    drug-discovery
    targeted-cancer-therapy
    cancer-therapy
    personalization
    pharma-companies
    bioinformatics
    NevaBio logo

    NevaBio

    Presumed Inactive
    ?
    Based on data collected from different sources by our team,
    there are indicators that suggest that this company is no longer active. However, this information may not be accurate. If you believe this information should be updated, please .
    For more details, you can read our .
    Immunotherapy for Cancer Prevention
    2017 B2B 1-10 Pre-Funding Undisclosed
    therapeutics
    oncology
    pharmaceuticals
    cancer-therapy
    immunotherapy
    pharma-companies

    Notifications settings

    Off
    Frequency:
    Select all

    Search Startups

    8 Results
    Funding Amount
    Funding Stages
    • Total Funding
      $82.35M
      Raised
      11
      Events
    • Private Funding
      $61.05M
      Raised
      4
      Rounds
    • Public Offerings
      $21.3M
      Raised
      5
      Offerings
    • M&A
      $0
      Raised
      2
      Deals

    Funding

    Rounds / Deals

    Funding Stage

    Number of Employees

    There aren’t any companies that match your search
    you can try looking for something else.

    Zion Medical logo
    Raised
    Undisclosed
    Zion Medical
    Presumed Inactive
    ?
    Based on data collected from different sources by our team,
    there are indicators that suggest that this company is no longer active. However, this information may not be accurate. If you believe this information should be updated, please .
    For more details, you can read our .
    Destruction of Cells Infected with HIV or Cancer
    Founded:2014
    Business Model:B2B
    Employees:1-10
    Funding Stage:Pre-Funding
    Cellect Biotechnology logo
    Raised
    $24.26M
    Cellect Biotechnology
    Presumed Inactive
    ?
    Based on data collected from different sources by our team,
    there are indicators that suggest that this company is no longer active. However, this information may not be accurate. If you believe this information should be updated, please .
    For more details, you can read our .
    Immune System Regeneration
    Founded:2011
    Business Model:B2B
    Employees:11-50
    Funding Stage:Public
    BioSight logo
    Raised
    $62.5M
    BioSight
    Presumed Inactive
    ?
    Based on data collected from different sources by our team,
    there are indicators that suggest that this company is no longer active. However, this information may not be accurate. If you believe this information should be updated, please .
    For more details, you can read our .
    Therapeutics for Oncology and Hematological Disorders
    Founded:1999
    Business Model:B2B
    Employees:1-10
    Funding Stage:Acquired
    CureTech logo
    Raised
    $4M
    CureTech
    Presumed Inactive
    ?
    Based on data collected from different sources by our team,
    there are indicators that suggest that this company is no longer active. However, this information may not be accurate. If you believe this information should be updated, please .
    For more details, you can read our .
    Cancer Immunotherapy
    Founded:2001
    Business Model:B2B
    Employees:51-200
    Funding Stage:Seed
    TanoMed logo
    Raised
    Undisclosed
    TanoMed
    Presumed Inactive
    ?
    Based on data collected from different sources by our team,
    there are indicators that suggest that this company is no longer active. However, this information may not be accurate. If you believe this information should be updated, please .
    For more details, you can read our .
    Immunotherapy Solutions for GI Cancers
    Founded:2020
    Business Model:B2B2C
    Employees:1-10
    Funding Stage:Pre-Funding
    Novitero logo
    Raised
    $0
    Novitero
    Presumed Inactive
    ?
    Based on data collected from different sources by our team,
    there are indicators that suggest that this company is no longer active. However, this information may not be accurate. If you believe this information should be updated, please .
    For more details, you can read our .
    Cancer Drugs to Bypass Resistance Mutations
    Founded:2014
    Business Model:B2B
    Employees:1-10
    Funding Stage:Pre-Funding
    NevaBio logo
    Raised
    Undisclosed
    NevaBio
    Presumed Inactive
    ?
    Based on data collected from different sources by our team,
    there are indicators that suggest that this company is no longer active. However, this information may not be accurate. If you believe this information should be updated, please .
    For more details, you can read our .
    Immunotherapy for Cancer Prevention
    Founded:2017
    Business Model:B2B
    Employees:1-10
    Funding Stage:Pre-Funding
    Unlock financial data
    Finder is provided for free by the non-profit organization Startup Nation Central.
    • Get unlimited search results
    • Save to custom lists - Watchlists
    • Get notified with news and updates
    • Connect with people
    And much more...
    I already have access,
    I already have access,